Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0033036 (
APC
)
10,214
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Using normal MDCK cells, and MDCK cells stably transfected with a temperature-sensitive viral src allele (pp60 ts-v-src), we have examined the composition and tyrosine phosphorylation of the E-cadherin complex. E-cadherin is a transmembrane calcium-dependent cell-cell adhesion molecule that is complexed with cytoplasmic proteins including alpha-catenin,
beta-catenin
, plakoglobin (gamma-catenin), and actin. We have identified two heterodimeric complexes which demonstrate that alpha-catenin interacts directly with
beta-catenin
, or with plakoglobin, in the absence of E-cadherin. beta-Catenin has previously been shown to bind directly to E-cadherin. We propose that E-cadherin associates with alpha-catenin, and thereby the actin cytoskeleton, via either
beta-catenin
or plakoglobin. We have further identified three new but related protein components of the E-cadherin complex, which are each cross-reactive by Western blot analysis to antibodies directed against p120, a phosphotyrosine substrate of src, and a phosphotyrosine, phosphoserine, and phosphothreonine substrate of growth factor-stimulated signaling pathways. Greater quantities of the p120-related proteins were found present in the E-cadherin immunoprecipitates of ts-src MDCK cells compared to normal MDCK cells, while two of the p120 cross-reactive species were significantly tyrosine phosphorylated in both normal and ts-src MDCK cells. The association of p120-related species with the E-cadherin complex adds them to our consideration of possible modulators of cadherin function. Likewise, the newly identified alpha-catenin-
beta-catenin
and alpha-catenin-plakoglobin dimers may have interesting biological properties, conceivably including the titration of catenins between cadherin and
APC
complexes.
...
PMID:The E-cadherin complex contains the src substrate p120. 753 97
The loss of epithelial differentiation in carcinomas, which is accompanied by higher mobility and invasiveness of the tumour cells, is often a consequence of reduced intercellular adhesion. The primary cause of the "scattering" of cells in invasive carcinomas appears to be a disturbance of the integrity of intercellular junctions, often involving the cell adhesion molecule E-cadherin. Permanent and transient molecular mechanisms can lead to the impairment of junction integrity of epithelial cells and thus to the progression of carcinomas towards a more invasive state. These include downregulation of E-cadherin expression and interaction between the adherens junction protein
beta-catenin
and the tumour suppressor gene product
APC
.
...
PMID:Adherens junction proteins in tumour progression. 755 58
The
APC
tumor-suppressor protein associates with
beta-catenin
, a cell adhesion protein that is upregulated by the WNT1 oncogene. We examined the effects of exogenous
APC
expression on the distribution and amount of
beta-catenin
in a colorectal cancer cell containing only mutant
APC
. Expression of wild-type
APC
caused a pronounced reduction in total
beta-catenin
levels by eliminating an excessive supply of cytoplasmic
beta-catenin
indigenous to the SW480 colorectal cancer cell line. This reduction was due to an enhanced rate of
beta-catenin
protein degradation. Truncated mutant
APC
proteins, characteristic of those associated with cancer, lacked this activity. Mutational analysis revealed that the central region of the APC protein, which is typically deleted or severely truncated in tumors, was responsible for the down-regulation of
beta-catenin
. These results suggest that the tumor-suppressor activity of mutant
APC
may be compromised due to a defect in its ability to regulate
beta-catenin
.
...
PMID:Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. 770 72
An enormous number of germline and somatic mutations have been identified in the
APC
tumor suppressor gene. Nearly all of these mutations result in premature polypeptide chain termination, but the consequences to APC protein function are unknown. Recent advances, including the identification of an oligomerization domain, the localization of several
beta-catenin
binding sites, some of which down-regulate
beta-catenin
in vivo, and the identification of a microtubule-binding domain in the carboxy-terminal region of
APC
, are beginning to provide some clues.
...
PMID:Mutations in the APC gene and their implications for protein structure and function. 774 28
beta-Catenin has emerged as an important component of the adherens junctions between epithelial cells. As a result of studies of its interaction with the
APC
gene product, it has been implicated in the development of colorectal cancer. alpha-Catenin,
beta-catenin
, E-cadherin and
APC
appear to mediate contact inhibition in epithelia. As part of the study of the organization of the
beta-catenin
gene, we have isolated yeast artificial chromosomes (YACs) to characterize its intron/exon structure. YAC fluorescence in situ hybridization analysis and polymerase chain reaction analysis of somatic cell hybrid DNAs show that
beta-catenin
maps in the 3p21-22 region, the location of tumour-suppressor genes deleted in small-cell lung cancer (SCLC) and other disorders. beta-Catenin YACs will provide a source of microsatellite markers useful in loss of heterozygosity studies to assess the importance of
beta-catenin
deletions in SCLC.
...
PMID:Yeast artificial chromosome cloning of the beta-catenin locus on human chromosome 3p21-22. 778 Jun 64
beta-Catenin is involved in the formation of adherens junctions of mammalian epithelia. It interacts with the cell adhesion molecule E-cadherin and also with the tumor suppressor gene product
APC
, and the Drosophila homologue of
beta-catenin
, armadillo, mediates morphogenetic signals. We demonstrate here that E-cadherin and
APC
directly compete for binding to the internal, armadillo-like repeats of
beta-catenin
; the NH2-terminal domain of
beta-catenin
mediates the interaction of the alternative E-cadherin and
APC
complexes to the cytoskeleton by binding to alpha-catenin. Plakoglobin (gamma-catenin), which is structurally related to
beta-catenin
, mediates identical interactions. We thus show that the
APC
tumor suppressor gene product forms strikingly similar associations as found in cell junctions and suggest that
beta-catenin
and plakoglobin are central regulators of cell adhesion, cytoskeletal interaction, and tumor suppression.
...
PMID:E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. 780 82
Beta-catenin
is a cytosolic protein originally identified through its association with the cadherin class of cell-adhesion proteins. However, recent studies have demonstrated that there are cadherin-independent pools of
beta-catenin
and that
beta-catenin
binds at least one other protein, the product of the tumor-suppressor gene
APC
. Furthermore,
beta-catenin
is the target of two signal transduction pathways mediated by the proto-oncogenes src and wnt-1. This raises the possibility that
beta-catenin
plays a pivotal role in balancing cellular responses to both adhesive and proliferative signals.
...
PMID:Beta-catenin: a common target for the regulation of cell adhesion by Wnt-1 and Src signaling pathways. 784 66
beta-catenin
was identified as a cytoplasmic cadherin-associated protein required for cadherin adhesive function (Nagafuchi, A., and M. Takeichi. 1989. Cell Regul. 1:37-44; Ozawa, M., H. Baribault, and R. Kemler. 1989. EMBO [Eur. Mol. Biol. Organ.] J. 8:1711-1717). Subsequently, it was found to be the vertebrate homologue of the Drosophila segment polarity gene product Armadillo (McCrea, P. D., C. W. Turck, and B. Gumbiner. 1991. Science [Wash. DC]. 254:1359-1361; Peifer, M., and E. Wieschaus. 1990. Cell. 63:1167-1178). Also, antibody perturbation experiments implicated
beta-catenin
in axial patterning of the early Xenopus embryo (McCrea, P. D., W. M. Brieher, and B. M. Gumbiner. 1993. J. Cell Biol. 123:477-484). Here we report that overexpression of
beta-catenin
in the ventral side of the early Xenopus embryo, by injection of synthetic
beta-catenin
mRNA, induces the formation of a complete secondary body axis. Furthermore, an analysis of
beta-catenin
deletion constructs demonstrates that the internal armadillo repeat region is both necessary and sufficient to induce axis duplication. This region interacts with C-cadherin and with the
APC
tumor suppressor protein, but not with alpha-catenin, that requires the amino-terminal region of
beta-catenin
to bind to the complex. Since alpha-catenin is required for cadherin-mediated adhesion, the armadillo repeat region alone probably cannot promote cell adhesion, making it unlikely that
beta-catenin
induces axis duplication by increasing cell adhesion. We propose, rather, that
beta-catenin
acts in this circumstance as an intracellular signaling molecule. Subcellular fractionation demonstrated that all of the
beta-catenin
constructs that contain the armadillo repeat domain were present in both the soluble cytosolic and the membrane fraction. Immunofluorescence staining confirmed the plasma membrane and cytoplasmic localization of the constructs containing the armadillo repeat region, but revealed that they also accumulate in the nucleus, especially the construct containing only the armadillo repeat domain. These findings and the
beta-catenin
protein interaction data offer several intriguing possibilities for the site of action or the protein targets of
beta-catenin
signaling activity.
...
PMID:Embryonic axis induction by the armadillo repeat domain of beta-catenin: evidence for intracellular signaling. 787 19
The tumor suppressor APC protein associates with the cadherin-binding proteins alpha- and
beta-catenin
. To examine the relationship between cadherin, catenins, and
APC
, we have tested combinatorial protein-protein interactions in vivo, using a yeast two-hybrid system, and in vitro, using purified proteins. beta-Catenin directly binds to
APC
at high and low affinity sites. alpha-Catenin cannot directly bind
APC
but associates with it by binding to
beta-catenin
. Plakoglobin, also known as gamma-catenin, directly binds to both
APC
and alpha-catenin and also to the
APC
-
beta-catenin
complex, but not directly to
beta-catenin
. beta-Catenin binds to multiple independent regions of
APC
, some of which include a previously identified consensus motif and others which contain the centrally located 20 amino acid repeat sequences. The
APC
binding site on
beta-catenin
may be discontinuous since neither the carboxyl- nor amino-terminal halves of
beta-catenin
will independently associate with
APC
, although the amino-terminal half independently binds alpha-catenin. The catenins bind to
APC
and E-cadherin in a similar fashion, but
APC
and E-cadherin do not associate with each other either in the presence or absence of catenins. Thus,
APC
forms distinct heteromeric complexes containing combinations of alpha-catenin,
beta-catenin
, and plakoglobin which are independent from the cadherin-catenin complexes.
...
PMID:The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin. 789 Jun 74
Mutations in the human
APC
gene are linked to familial adenomatous polyposis and to the progression of sporadic colorectal and gastric tumors. To gain insight into
APC
function,
APC
-associated proteins were identified by immunoprecipitation experiments. Antibodies to
APC
precipitated a 95-kilodalton protein that was purified and identified by sequencing as
beta-catenin
, a protein that binds to the cell adhesion molecule E-cadherin. An antibody specific to
beta-catenin
also recognized the 95-kilodalton protein in the immunoprecipitates. These results suggest that
APC
is involved in cell adhesion.
...
PMID:Association of the APC gene product with beta-catenin. 825 18
1
2
3
4
5
6
7
8
9
10
Next >>